Upstate Active Clinical Trials
Study Title:
Outcomes of Autism Treatment Using NaltrexoneWhat is the purpose of the study? (in Layman's terms, please describe the study)
The purpose of this study is to collect information from the patients we treat for autism spectrum disorders in order to evaluate our treatment methods and report the outcomes of our treatment approaches in medical journals.Upstate Institutional Review Board (IRB) Number:
721816Study Phase:
N/APatient Age Group:
AdultsPrincipal Investigator:
Brian JohnsonWho can I contact for more information?
Name: Jacqueline M Hattersley
Phone: 315-464-3130
Email: hattersj@upstate.edu